Costs on a downward trend
Modulight's Q1 revenue missed expectations. However, the losses were lower than expected due to a reduction in costs. The transition to growth mode appears to be taking longer than expected, so we are lowering our revenue forecasts for the next few years. With cost forecasts falling at the same time, the impact of the fall in revenue will remain moderate. The valuation outlook remains high due to lagging growth, both in absolute terms and relative to peers. However, the realization of brisk growth could quickly turn the valuation picture in a more attractive direction.
Login required
This content is only available for logged in users
Modulight
Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.
Read more on company pageKey Estimate Figures27.04.
| 2023 | 24e | 25e | |
|---|---|---|---|
| Revenue | 4.0 | 6.0 | 8.4 |
| growth-% | -12.46 % | 48.04 % | 40.94 % |
| EBIT (adj.) | -12.1 | -9.4 | -5.7 |
| EBIT-% (adj.) | -301.39 % | -158.31 % | -67.41 % |
| EPS (adj.) | -0.28 | -0.22 | -0.10 |
| Dividend | 0.00 | 0.00 | 0.00 |
| Dividend % | |||
| P/E (adj.) | - | - | - |
| EV/EBITDA | - | - | - |
